Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72 -associated frontotemporal dementia and amyotrophic lateral sclerosis (2021)
Attributed to:
The UK GENetic Frontotemporal dementia Initiative (UK GENFI)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.12.14.21267456
Publication URI: http://dx.doi.org/10.1101/2021.12.14.21267456
Type: Preprint